...
首页> 外文期刊>Protein engineering design & selection: PEDS >Tethered-variable C-L bispecific IgG: an antibody platform for rapid bispecific antibody screening
【24h】

Tethered-variable C-L bispecific IgG: an antibody platform for rapid bispecific antibody screening

机译:TETHERED-变量C-L BISPECIFIC IgG:用于快速双特异性抗体筛选的抗体平台

获取原文
获取原文并翻译 | 示例

摘要

Bispecific antibodies offer a clinically validated platform for drug discovery. In generating functionally active bispecific antibodies, it is necessary to identify a unique parental antibody pair to merge into a single molecule. However, technologies that allow high-throughput production of bispecific immunoglobulin Gs (BsIgGs) for screening purposes are limited. Here, we describe a novel bispecific antibody format termed tethered-variable CL BsIgG (tcBsIgG) that allows robust production of intact BsIgG in a single cell line, concurrently ensuring cognate light chain pairing and preserving key antibody structural and functional properties. This technology is broadly applicable in the generation of BsIgG from a variety of antibody isotypes, including human BsIgG1, BsIgG2 and BsIgG4. The practicality of the tcBsIgG platform is demonstrated by screening BsIgGs generated from FGF21-mimetic anti-Klotho-beta agonistic antibodies in a combinatorial manner. This screen identified multiple biepitopic combinations with enhanced agonistic activity relative to the parental monoclonal antibodies, thereby demonstrating that biepitopic antibodies can acquire enhanced functionality compared to monospecific parental antibodies. By design, the tcBsIgG format is amenable to high-throughput production of large panels of bispecific antibodies and thus can facilitate the identification of rare BsIgG combinations to enable the discovery of molecules with improved biological function.
机译:双特异性抗体提供临床验证的药物发现平台。在产生功能活性的双特异性抗体时,必须鉴定独特的亲本抗体对以合并成单个分子。然而,允许用于筛选目的的双特异性免疫球蛋白Gs(Bsiggs)的高通量产生的技术受到限制。这里,我们描述了一种新的双特异性抗体形式,其允许在单个细胞系中稳健地生产完整的Bsigg,并同时确保对同源轻链配对和保持关键抗体结构和功能性质的鲁棒生产。该技术广泛适用于来自各种抗体同种型的Bsigg,包括人Bsigg1,Bsigg2和Bsigg4。通过以组合方式筛选由FGF21 - 模拟抗-Klotho-β激动抗体产生的Bsiggs来证明TCBSIGG平台的实用性。该筛选鉴定了相对于亲本单克隆抗体的增强的激动活性的多种Biepitopic组合,从而表明与单特异性父母抗体相比,Biepitopic抗体可以获得增强的功能。通过设计,TCBSIGG格式可用于双特异性抗体的大面板的高通量产生,因此可以促进罕见的BSIGG组合,以使得能够发现具有改善的生物功能的分子。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号